Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Appili Therapeutics Inc Class A (APLIF)
OTHER OTC:APLIF
Holding APLIF?
Track your performance easily
APLIF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.01 - $0.05
Previous Close$0.03
Volume25.60K
Average Volume (3M)151.43K
Market Cap
$3.29M
Enterprise Value$10.00M
Total Cash (Recent Filing)C$301.26K
Total Debt (Recent Filing)C$10.05M
Price to Earnings (P/E)―
Beta1.29
Next Earnings
Feb 18, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding121,266,120
10 Day Avg. Volume27,410
30 Day Avg. Volume151,425
Standard Deviation0.26
R-Squared0.00814
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)-0.26
Price to Sales (P/S)5.13
Price to Cash Flow (P/CF)-8.00
P/FCF Ratio1.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Appili Therapeutics Inc Class A News
PremiumCompany Announcements
Appili Therapeutics Moves Forward with Aditxt Acquisition
PremiumCompany Announcements
Appili Therapeutics Highlights Progress and Shareholder Support
PremiumCompany Announcements
Appili Shareholders Approve Acquisition by Aditxt
PremiumCompany Announcements
Appili Therapeutics’ FDA Alignment and Aditxt Acquisition
APLIF FAQ
What was Appili Therapeutics Inc Class A’s price range in the past 12 months?
Appili Therapeutics Inc Class A lowest stock price was $0.01 and its highest was $0.05 in the past 12 months.
What is Appili Therapeutics Inc Class A’s market cap?
Currently, no data Available
When is Appili Therapeutics Inc Class A’s upcoming earnings report date?
Appili Therapeutics Inc Class A’s upcoming earnings report date is Feb 18, 2025 which is in 57 days.
How were Appili Therapeutics Inc Class A’s earnings last quarter?
Appili Therapeutics Inc Class A released its earnings results on Nov 14, 2024. The company reported -$0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.007.
Is Appili Therapeutics Inc Class A overvalued?
According to Wall Street analysts Appili Therapeutics Inc Class A’s price is currently Overvalued.
Does Appili Therapeutics Inc Class A pay dividends?
Appili Therapeutics Inc Class A does not currently pay dividends.
What is Appili Therapeutics Inc Class A’s EPS estimate?
Appili Therapeutics Inc Class A’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Appili Therapeutics Inc Class A have?
Appili Therapeutics Inc Class A has 121,266,120 shares outstanding.
What happened to Appili Therapeutics Inc Class A’s price movement after its last earnings report?
Appili Therapeutics Inc Class A reported an EPS of -$0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Appili Therapeutics Inc Class A?
Currently, no hedge funds are holding shares in APLIF
---
Appili Therapeutics Inc Class A Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
13.63%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-20.57%
Trailing 12-Months
Company Description
Appili Therapeutics Inc Class A
Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes major programs namely ATI-2307, ATI-1701, ATI-1503, ATI-1501 and Favipiravir.
---
Technical Analysis
---